Screener / Precision Oncology & Liquid Biopsy / Guardant Health
GH · NASDAQ
Guardant Health
Compliant
Under AAOIFI Standard 21, Guardant Health is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.
TickerGH
ExchangeNASDAQ
SectorPrecision Oncology & Liquid Biopsy
Full ratios for Guardant Health (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Guardant Health or any other security.